Genetic Technologies (GENE) Fails to deliver data

Key failure to deliver metrics for Genetic Technologies:

• Last SEC data release: 2024-10-11
• Last 15 days FTD volume: N/A
• Last 3 months FTD volume: N/A
• Last year FTD volume: N/A

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Genetic Technologies (GENE) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Genetic Technologies (GENE) - since 2019

Genetic Technologies (GENE) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Eterna Therapeutics ERNA	£0.04 M	£0.18 M	🇺🇸 USA
Myriad Genetics MYGN	£0.02 M	£0.99 M	🇺🇸 USA
LabCorp LH	N/A	£19.44 M	🇺🇸 USA
Quest Diagnostics DGX	£0.74 M	£8.18 M	🇺🇸 USA
Compugen CGEN	£0.04 M	£1.9 M	🇮🇱 Israel
Danaher DHR	£0.14 B	£0.25 B	🇺🇸 USA
Thermo Fisher Scientific TMO	£34.32 M	£0.29 B	🇺🇸 USA
Neogen NEOG	£3.22 M	£19.09 M	🇺🇸 USA